News
05-13-2011, 07:10 AM
In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer. Patients with these larger breast tumors have two options, says Matthew J. Ellis, MD, PhD, of Washington University School of Medicine in St...
More... (http://www.medicalnewstoday.com/releases/224688.php)
More... (http://www.medicalnewstoday.com/releases/224688.php)